Sunshine Act Deadline Is Still Cloudy As Registration Not Yet Available
This article was originally published in The Pink Sheet Daily
Executive Summary
Physician payment data is coming due, but stakeholders continue to press CMS for clarity on the deadline for the first set of information since conflicting instructions are on the agency’s website.
You may also be interested in...
Six Months Till Sunrise: CMS Allows Extra Time For Firms To Collect Physicians Payment Data
Drug makers get three more months to comply than the proposed rule offered; firms must send the data by March 31, 2014, to CMS, which plans to make the information available on a public website by Sept. 30, 2014.
Woodcock Takes On Rare Disease Challenges In Retirement, Keeps FDA, Industry At Arm’s Length
Recently retired US FDA Principal Deputy Commissioner Janet Woodcock will be advising the Haystack Project, with the goal of helping rare disease organizations encourage creativity in drug development programs without jeopardizing regulatory success, Woodcock told the Pink Sheet in an interview.
Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests
The rulemaking is supposed to formalize the Patent Trial and Appeal Board process, which has been in an interim status since a Supreme Court decision, giving manufacturers more ability to request oversight of the decisions.